Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

PRELIMINARY RESULTS FROM A MULTICENTER PHASE 2/3 STUDY OF NEXT-GENERATION SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR OSIVELOTOR (GBT021601) FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE
SL Sarafa, SU Abdullahib, AM Akinsetec, FA Fasolad, M Idowue, S Penningtonf, WB Ershlerg, MP Staggh, EA Lisboni, F Montealegre-Golcheri
a University of Illinois College of Medicine, Chicago, United States
b Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria
c College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria
d College of Medicine, University of Ibadan/University College Hospital, Ibadan, Nigeria
e University of Texas Health McGovern Medical School, Houston, United States
f Mississippi Center for Advanced Medicine, Madison, United States
g Inova Adult Sickle Center, Schar Cancer Institute, Fairfax, United States
h Our Lady of the Lake Cancer Institute, Baton Rouge, United States
i Pfizer Inc, New York, United States
Ver más
Lido
491
Vezes
que se leu este artigo
172
Total PDF
319
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 6 24 15 39
2025 5 47 12 59
2025 4 45 9 54
2025 3 52 10 62
2025 2 33 21 54
2025 1 28 16 44
2024 12 23 29 52
2024 11 35 37 72
2024 10 32 23 55

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy